NGVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ingevity Corp (NGVT) is not a strong buy for a beginner, long-term investor at this moment. Despite some positive technical indicators, the company's financial performance is significantly weak, and there are no recent positive catalysts or strong analyst support to justify an immediate investment. The stock is better suited for monitoring rather than immediate action.
The technical indicators show mixed signals. The MACD is positive and expanding, suggesting bullish momentum. The RSI is neutral at 69.804, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot point (67.392) and nearing resistance levels (R1: 70.889, R2: 73.05). However, the stock's historical trend suggests a higher probability of short-term declines (-3.07% in the next week).
The SwingMax signal from 2026-03-17 indicates a 4.15% price increase since then, and the MACD suggests bullish momentum. Technical moving averages are also aligned positively.
The company's financial performance in Q4 2025 is extremely weak, with a 609.64% drop in net income and a 615.22% drop in EPS YoY. Analysts are neutral, with Wells Fargo maintaining an Equal Weight rating and expressing uncertainty about the company's business alternatives. Additionally, there is no recent news or significant hedge fund or insider trading activity to act as a positive catalyst.
In Q4 2025, revenue dropped by -3.11% YoY to $255.1M. Net income plummeted by -609.64% YoY to -$84.6M, and EPS fell by -615.22% YoY to -2.37. Gross margin also decreased by -9.28% YoY to 34.42%. Overall, the financials indicate significant challenges for the company.
Wells Fargo recently raised the price target to $65 from $60 but maintained an Equal Weight rating. The firm remains cautious due to uncertainties surrounding the company's business restructuring and future direction.
